Fully implantable brain chip aims to restore real speech
A U.S. neurotechnology startup called Paradromics is gaining momentum in the fast-growing field of brain-computer interfaces. The FDA has approved its first human trial built to test whether its fully implantable device can restore speech for people with paralysis. This milestone gives the Austin company a strong position in a competitive space, shaping the future of neural technology.Paradromics received Investigational Device Exemption status for the Connect-One Early Feasibility Study using […]